Enovis Corp (ENOV) Stock Analysis

Enovis Corp (ENOV) is a publicly traded company in the HEALTHCARE sector. It trades at $21.70, carries a market capitalization of $1.28B. This page summarizes the public market data, fundamentals, and frequently asked questions for ENOV, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE

Key Metrics

• Price: $21.70
• Market Cap: $1.28B
• EPS: $-19.89
• 52-Week High: $36.82
• 52-Week Low: $21.00

Market Sentiment

Enovis Corp currently has a Bullish sentiment score of 0.41.

About Enovis Corp

Enovis Corporation is a prominent global medical technology company based in Wilmington, Delaware, dedicated to advancing orthopedic and rehabilitation solutions aimed at improving patient outcomes. Renowned for its commitment to innovation, Enovis employs state-of-the-art research and development to produce high-quality medical devices and therapies that address the evolving needs of healthcare providers and patients alike. The company's strategic initiatives prioritize sustainability and co...

GNG Research Analysis

GNG Research scores Enovis Corp (ENOV) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ENOV.

Frequently Asked Questions

Does ENOV pay dividends?

Enovis Corp (ENOV) does not currently pay a regular dividend.

What is ENOV's market cap?

Enovis Corp (ENOV) has a market capitalization of $1.28B with a current stock price of $21.70.